United Therapeutics $216m deal for SteadyMed clears HRS Act waiting period
United Therapeutics (NSDQ:UTHR) said today that it stepped closer to completing its $216 million acquisition of SteadyMed (NSDQ:STDY) after terminating the the HSR Act waiting period. The merger combines two companies that were in court as recently as last November, fighting over patents covering treprostinil, the active ingredient in both companies’ lead products. Read the whole story on our sister site, Drug Delivery Business News The post United Therapeutics $216m deal for SteadyMed clears HRS Act waiting period appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 20, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Drug-Device Combinations Mergers & Acquisitions Pharmaceuticals Vascular SteadyMed Therapeutics United Therapeutics Source Type: news

Meril Aims for Emerging Markets with its TAVR Device
Yet another company is throwing its hat into the transcatheter aortic valve replacement system (TAVR) market. However, Meril Lifesciences is going a different route than other established firms in the space and is initially targeting emerging markets. Meril has been around for 10 years and has been developing its MyVal TAVR technology for about six of those. The company’s success in TAVR lies around the fact that larger organizations don’t consider emerging markets as the first option. The company said it would seek out approval in India first and eventually make its way to developed markets. “We are posi...
Source: MDDI - July 20, 2018 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Business Source Type: news

B. Braun to Pick Up NxStage ’s Bloodlines Business
Braun Medical is set to acquire NxStage Medical’s bloodlines business. The potential acquisition is subject to Federal Trade Commission approval and is contingent upon the closing of the $2 billion merger between NxStage and Waltham, MA-based Fresenius Medical Holdings. The bloodlines business is operated under the Medisystems name. “We are pleased to add the Streamlinebloodline to our dialysis product portfolio,” Sam Amory, Vice President of B. Braun Medical, said in a release. “Although we have been selling Streamline for many years, this acquisition will allow us to more broadly promote Streamlin...
Source: MDDI - July 20, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Tendyne investors sue Abbott over $50m milestone
Investors in Tendyne Holdings yesterday sued Abbott (NYSE:ABT) over a $50 million milestone payment, alleging that the healthcare giant dragged its heels on obtaining a regulatory approval that would have triggered a $50 million milestone payment. Abbott in September 2015 paid $225 million up front for the stake it didn’t already own in Roseville, Minn.-based Tendyne, which was developing a transcatheter replacement mitral valve. The deal also included a $50 million milestone provision contingent on the device winning CE Mark approval in the European Union before Dec. 31, 2017, and that ...
Source: Mass Device - July 20, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Legal News Mergers & Acquisitions Replacement Heart Valves Abbott Tendyne Holdings Source Type: news

Boston Sci Just Won ’t Stop Buying Companies
There really doesn’t seem to be in sight to Boston Scientific’s recent buying spree. This time the Marlborough, Mass.-based company is picking up Claret Medical for about $220 million in upfront cash and a potential reimbursement-based milestone payment of up to $50 million. The deal is set to close sometime in the third quarter of 2018. Santa Rosa, CA-based Claret has developed and received clearance for the Sentinel Cerebral Embolic Protection System. The device is used to protect the brain during certain interventional procedures, predominately in patients undergoing transcatheter aortic valve replacement(TA...
Source: MDDI - July 20, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Cardiovascular Source Type: news

Tenet shedding hospitals, debt as UnitedHealth explores Conifer acquisition
Dallas-based Tenet Healthcare Corp. is whittling down its debt as it sells off hospitals and explores a sale of its Frisco-based subsidiary, Conifer Health Solutions. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 20, 2018 Category: Pharmaceuticals Authors: Bill Hethcock Source Type: news

Boston Scientific puts $270m on the table for Claret Medical
Boston Scientific (NYSE:BSX) said today that it agreed to pay as much as $270 million to acquire Claret and its Sentinel device. Marlborough, Mass.-based Boston Scientific said the deal involves an ip-front cash payment of $220 million and another $50 million pegged to a reimbursement milestone. Claret’s Sentinel device is designed to trap and remove debris dislodged during transcatheter aortic valve replacements to prevent stroke and other neurological damage. After landing CE Mark approval in the European Union in 2014, Santa Rosa, Calif.-based Claret won de novo clearance from the FDA last year for the Sentin...
Source: Mass Device - July 20, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Replacement Heart Valves Wall Street Beat Boston Scientific Claret Medical Inc. Source Type: news

Paramedics Plus Announces Corporate Rebranding, Changes Name to PatientCare Logistics Solutions
TYLER, Texas (July 19, 2018) – Paramedics Logistics Operating Company, LLC d/b/a Paramedics Plus, a leading provider of ground-based 911 emergency ambulance and other critical healthcare logistics solutions, has been rebranded as PatientCare Logistics Solutions, LLC (“PatientCare” or the “Company”). The corporate level rebranding reflects the Company’s continued commitment to provide the highest quality of care for each and every patient served. PatientCare will maintain continuity with the service brands in the municipalities that the Company currently serves including: Sunstar Paramedi...
Source: JEMS Administration and Leadership - July 20, 2018 Category: Emergency Medicine Authors: Patient Care Logistics Solutions Tags: News Administration and Leadership Industry News Source Type: news

As Mega-Mergers Stumble, Hospitals Pursue Diverse Alliances
Non-profit health system mergers are fraught with risk. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 19, 2018 Category: Pharmaceuticals Authors: Mergermarket, Contributor Source Type: news

B Braun inks deal to buy NxStage ’ s bloodlines biz
B. Braun said today it inked a deal to acquire the NxStage Medical‘s (NSDQ:NXTM) bloodlines business, which operates under the Medisystems moniker. Bethlehem, Penn.-based B. Braun did not release any details of the acquisition, and has not revealed how it plans to integrate the business into its existing product lines. “We are pleased to add the Streamline bloodline to our dialysis product portfolio. Although we have been selling Streamline for many years, this acquisition will allow us to more broadly promote Streamline’s benefits as part of our transformative system of products, which includes...
Source: Mass Device - July 19, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions B. Braun NxStage Medical Inc. Source Type: news

Walmart hires former Humana exec — fueling speculation of acquisition
A recent hire by Bentonville, Arkansas-based retail titan Walmart Inc. resurrected speculation that it might strike a deal to work more closely with Louisville-based Humana Inc. Walmart hired Sean Slovenski as senior vice president of health and wellness for Walmart U.S., according to an internal memo from Greg Foran, president and CEO of Walmart U.S., which was provided to MBJ's sister publication, Louisville Business First. Slovenski will join Walmart on Aug. 1 and wi ll report directly to Foran,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 19, 2018 Category: Biotechnology Authors: Chris Larson Source Type: news

Rite Aid-Albertsons Comeback Hinges On Narrow Pharmacy Networks
Albertsons and Rite Aid plan to escalate the narrow pharmacy network strategy should their merger be approved so the larger company can compete with CVS Health, Walgreens and Walmart. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 19, 2018 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NASDAQ:WBA NYSE:CVS NYSE:RAD NYSE:WMT NYSE:AET Source Type: news

Labeling theory and life stories of juvenile delinquents transitioning into adulthood - Abrah PB.
This article examines this assertion with the life story of 23 juvenile delinquents. The objective of the study was to gain i... (Source: SafetyLit)
Source: SafetyLit - July 19, 2018 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

State says Beth Israel-Lahey merger could cost Mass. millions
The state ’s health care watchdog has strongly criticized a proposed mega-merger between Lahey Health, Beth Israel Deaconess Medical Center and three community hospitals, saying the deal would raise health care spending by $168 million to $251 million. At a Health Policy Commission hearing on Wednesday, co mmission staff said they had reviewed the proposed merger between Lahey, BI, New England Baptist Hospital, Anna Jaques Hospital and Mount Auburn Hospital, and found that the group would create… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 18, 2018 Category: American Health Authors: Jessica Bartlett Source Type: news

State says Beth Israel-Lahey merger could cost Mass. millions
The state ’s health care watchdog has strongly criticized a proposed mega-merger between Lahey Health, Beth Israel Deaconess Medical Center and three community hospitals, saying the deal would raise health care spending by $168 million to $251 million. At a Health Policy Commission hearing on Wednesday, co mmission staff said they had reviewed the proposed merger between Lahey, BI, New England Baptist Hospital, Anna Jaques Hospital and Mount Auburn Hospital, and found that the group would create… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 18, 2018 Category: Biotechnology Authors: Jessica Bartlett Source Type: news

Merger to create one of Cincinnati ’s largest doctor groups
Suburban Pediatric Associates, a 40-year-old practice with locations in Forest Park, Liberty Township and Mason, revealed today that it plans to merge with Mason-based Premier Pediatric Group on Aug. 1. All four practice locations will operate as Suburban Pediatric Associates, which will become the 24th-largest physician group in Greater Cincinnati, according to the most recent Business Courier research. The group will include 15 pediatricians after the merger, edging out two Kentucky physician … (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 18, 2018 Category: Biotechnology Authors: Barrett J. Brunsman Source Type: news

Abbott Labs raises 2018 earnings forecast, shares hit record high
Abbott Laboratories raised its full-year earnings forecast and topped estimates for quarterly profit on Wednesday, powered by demand for its glucose monitoring device for diabetics and gains from its multibillion dollar acquisitions. (Source: Reuters: Health)
Source: Reuters: Health - July 18, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Hits Baxter with Warning Letter in Connection with Claris Acquisition
A full year after acquiring Claris Injectables, FDA has hit Baxter with a warning letter in connection with the agency’s inspection of the acquired facilities in Ahmedabad, India. Baxter added Claris to the pharmaceuticals side of its business last year and the $625 million deal is expected to provide a foundational growth platform for the company. FDA began an inspection of the Claris facilities the same day the deal closed, July 27, 2017, which resulted in a Form-483 noting several observations. The company responded to the 483 on Aug. 25 and said in a recent regulatory filing with the Securities and Exchange Commi...
Source: MDDI - July 18, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance Business Source Type: news

New details emerge on TapImmune merger
A preliminary filing with the SEC reveals the strategy – and finances – behind TapImmune's pending acquisition and relocation. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 18, 2018 Category: Pharmaceuticals Authors: Will Robinson Source Type: news

Advertising regulation needs strengthening to better regulate alcohol marketing on social media, new research finds
New research published today (18 July 2018) shows the significant role that drinking venues and alcohol brands play in marketing alcohol products to young people on social media. The report highlights how the regulatory system for alcohol marketing (under the UK advertising Codes of Practice regulated by the Advertising Standards Authority) is struggling to keep up with the pace and nature of technological change and needs to be strengthened – taking particular account of marketing by venues as well as brands – to reflect the central role of social media activity in young people’s drinking occasions. The ...
Source: Alcohol Research UK - July 17, 2018 Category: Addiction Authors: Julie Symes Tags: News Source Type: news

Natus Medical lifts Kennedy to the corner office | Personnel Moves – July 17, 2018
Natus Medical (Nasdaq: BABY) said last week that its current CEO Jim Hawkins is retiring from their position, with current chief financial officer Jonathan Kennedy slated to take over as prez & chief exec. Kennedy has operated as CFO since April 2013, while the retiring Hawkins spent 14 years as the chief exec, the Pleasanton, Calif.-based company said. “It has been a privilege to serve as Natus’ CEO over the past 14 years and I thank Natus’ talented employees for their hard work and partnership on this journey. I am proud of all that we have accomplished in building Natus into the mark...
Source: Mass Device - July 17, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Analogic berkshiresterilemanufacturing evidentmedical hancockjaffelabs Helius Medical Technologies MedCrypt Myomo Inc Natus Medical Inc. Source Type: news

Polares Medical raises $25m
Preclinical Swiss medtech group Polares Medical said today it closed a $25 million funding round to support its mitral valve repair technologies. Funding in the round was led by Decheng Capital and joined by Endeavour Vision, IDO Investments, Earlybird Venture Capital and Wellington Partners, the company said. Polares Medical is developing a “hemi-replacement” solution for the mitral valve through which the posterior leaflet is replaced with a prosthetic leaflet designed to enhance coaptation with the native anterior leaflet. “Hemi-replacement represents a new treatment paradigm for mitral regurgitation, ...
Source: Mass Device - July 17, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Funding Roundup polaresmedical Source Type: news

The first decade of web-based sports injury surveillance: descriptive epidemiology of injuries in US high school girls' field hockey (2008-2009 through 2013-2014) and National Collegiate Athletic Association women's field hockey (2004-2005 through 2013-2014) - Lynall RC, Gardner EC, Paolucci J, Currie DW, Knowles SB, Pierpoint LA, Wasserman EB, Dompier TP, Comstock RD, Marshall SW, Kerr ZY.
CONTEXT:   The advent of Web-based sports injury surveillance via programs such as the High School Reporting Information Online system and the National Collegiate Athletic Association Injury Surveillance Program has aided the acquisition of data for girl... (Source: SafetyLit)
Source: SafetyLit - July 17, 2018 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Will IHH Healthcare's acquisition of Fortis nurse it out of ICU?
With its own mixed track record in India, the coup can easily turn into a winner ’s curse for IHH. (Source: The Economic Times)
Source: The Economic Times - July 17, 2018 Category: Consumer Health News Source Type: news

Creo Medical raises $64m
Creo Medical Group (LON:CREO) said last Friday it raised $64.2 million (GBP £48.5 million) through three private placements. The Chepstow, Wales-based company said it sold approximately 38.8 million shares at $1.66 per share (GBP £1.25) and that the placements were “significantly oversubscribed.” Creo Medical said it expects to see net proceeds from the offering of approximately $60.9 million. Cenkos Securities acted as the placement agent during the offering, Creo said. Funding from the round will be used to support the company’s clinical education program, to add additional distribution...
Source: Mass Device - July 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Funding Roundup Creo Medical Source Type: news

SuperSonic Imagine wins FDA nod, CE Mark for Aixplorer Mach 30 ultrasound
SuperSonic Imagine said today it won FDA 510(k) clearance and CE Mark approval in the European Union for its next-gen Aixplorer Mach 30 ultrasound system. The France-based company touted that the newly cleared system features its UltraFast imaging and enhanced performance over previous models of the device. The Aixplorer features the company’s SonicPad touchpad interface and improved B-mode image quality. The Aixplorer Mach 30 also features ShearWave elastography intended to allow for real-time, reliable, quantitative and reproducible 2D and 3D visualization of tissue stiffness. “The FDA 510(k) and CE Mark are ...
Source: Mass Device - July 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Imaging Regulatory/Compliance Ultrasound SuperSonic Imagine S.A. Source Type: news

ProPharma acquires European company
Overland Park-based ProPharma Group has acquired a Netherlands company that provides compliance, technical support and other services to the pharmaceutical industry. ProPharma, which announced the deal in a Monday release, did not disclose the price or other terms of the deal to acquire Xendo Holdings BV. ProPharma provides compliance consulting to pharmaceutical, biotech and medical device companies worldwide. It employs about 100 people in the metro area. T he acquisition will include Swedish… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 16, 2018 Category: Biotechnology Authors: Russell Gray Source Type: news

Albertsons Touts E-Commerce Expansion Ahead Of Rite Aid Deal
Albertsons plans to expand health and pharmacy “eCommerce offerings” ahead of its merger with Rite Aid. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 16, 2018 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NASDAQ:WBA NYSE:CVS NYSE:RAD NYSE:SWY NYSE:WMT Source Type: news

Orlando Health to buy 25 acres for future expansion
Orlando Health has entered into a contract with EHOF Acquisitions II LLC to buy 25 acres in Osceola County. The $3.8 billion nonprofit health care provider expects to close on the property at 8011 Osceola Polk Line Road in Davenport by early 2019. The organization has not yet announced its purpose for the site. Master development and infrastructure-related activities for the site are expected to begin t his fall. “This superior site, just south of Central Florida’s bustling tourist corridor… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 16, 2018 Category: Health Management Authors: Ryan Lynch Source Type: news

Orlando Health to buy 25 acres for future expansion
Orlando Health has entered into a contract with EHOF Acquisitions II LLC to buy 25 acres in Osceola County. The $3.8 billion nonprofit health care provider expects to close on the property at 8011 Osceola Polk Line Road in Davenport by early 2019. The organization has not yet announced its purpose for the site. Master development and infrastructure-related activities for the site are expected to begin t his fall. “This superior site, just south of Central Florida’s bustling tourist corridor… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 16, 2018 Category: Biotechnology Authors: Ryan Lynch Source Type: news

Abbott ’ s St. Jude Medical must face negligence suit over Riata leads
Abbott (NYSE:ABT) subsidiary St. Jude Medical must face a negligence lawsuit brought over its recalled Riata defibrillator leads after a federal judge ruled that the case is not rpeempted by fedral rules. Plaintiff Kristen Bull was implanted with a St. Jude implantable cardioverter defibrillator using Riata leads in November 2010, just a month before the company pulled the silicone-coated wires after finding that some of the internal conductors had worn through their insulation. In November 2011 the company warned that the Riata leads appeared to fail more frequently than previously reported, leadi...
Source: Mass Device - July 16, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Legal News Product Liability Abbott Cardiac Rhythm Management stjudemedical Source Type: news

Here are Q2's 10 biggest VC-backed exits from the Bay Area
Here is a look at the 10 biggest venture-backed IPOs and acquisitions from the first half of what has been a very active year for such exits. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 13, 2018 Category: Biotechnology Authors: Cromwell Schubarth Source Type: news

Here are Q2's 10 biggest VC-backed exits from the Bay Area
Here is a look at the 10 biggest venture-backed IPOs and acquisitions from the first half of what has been a very active year for such exits. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 13, 2018 Category: American Health Authors: Cromwell Schubarth Source Type: news

Key Surgical acquires Encompas Unlimited
Key Surgical recently announced that it has acquired Encompas Unlimited to expand its endoscopy product offerings. The financial details of the deal were not disclosed. This is the second acquisition that Key Surgical has completed after merging with Interlock Medizintechnik last year. Emcompas specializes in manufacturing, assembling and distribution a variety of endoscopy accessories and supplies. Get the full story on our sister site, Medical Design & Outsourcing. The post Key Surgical acquires Encompas Unlimited appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 13, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Blog encompasunlimited keysurgical Source Type: news

Here are Q2's 10 biggest VC-backed exits from the Bay Area
Here is a look at the 10 biggest venture-backed IPOs and acquisitions from the first half of what has been a very active year for such exits. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 13, 2018 Category: Health Management Authors: Cromwell Schubarth Source Type: news

Here are Q2's 10 biggest VC-backed exits from the Bay Area
Here is a look at the 10 biggest venture-backed IPOs and acquisitions from the first half of what has been a very active year for such exits. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 13, 2018 Category: Biotechnology Authors: Cromwell Schubarth Source Type: news

Here are the top 5 medtech stories of mid-2018
This article is by managing editor Chris Newmarker and associate editors Fink Densford and Sarah Faulkner. Listen to a webcast of Densford and Faulkner discussing mid-2018 news trends here.  The post Here are the top 5 medtech stories of mid-2018 appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 13, 2018 Category: Medical Devices Authors: Chris Newmarker Tags: Business/Financial News Emerging Markets Food & Drug Administration (FDA) Mergers & Acquisitions News Well Regulatory/Compliance AI Boston Scientific China Donald Trump GE Healthcare IBM Watson Health Pelvic Mesh Lawsuits Stryker Source Type: news

Scottsdale health tech firm raises $18M for latest acquisition, plans big hiring spree
Company officials say they expect to hire upwards of 200 more workers across the country by year-end. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 13, 2018 Category: American Health Authors: Angela Gonzales Source Type: news

Consolidation Among Radiology Services Providers Hitting Fevered Pitch
Readout: Radiology practices are rapidly getting rolled up into large practice groups, due to hospital consolidation, reimbursement model changes and other factors. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 13, 2018 Category: Pharmaceuticals Authors: Mergermarket, Contributor Tags: NYSE:MD NYSE:EVHC NYSE:KKR Source Type: news

Oxford Nanopore Technologies Raises $180 Million to Expand Development of Its Revolutionary Hand-held DNA Sequencer; Might Medical Labs Get a POCT Solution?
Popularity of the pocket-sized gene-sequencing device continues to prove that DNA testing away from clinical laboratories in remote clinics and outlying field laboratories is not just possible, but in some cases preferable Once again, Oxford Nanopore Technologies (ONT) is demonstrating how next-generation gene sequencing technology can make it cheaper, simpler, and faster to sequence without […] (Source: Dark Daily)
Source: Dark Daily - July 13, 2018 Category: Laboratory Medicine Authors: Michael Tags: Clinical Laboratory/Pathology Automation, Analyzers, Testing Systems Digital Pathology Instruments & Equipment Lab and Pathology Mergers, Acquisitions, Valuations Laboratory Instruments & Laboratory Equipment Laboratory Management and Operations Source Type: news

CTG exec: Managing data vital during health care mergers
Hamish Stewart-Smith, CTG's managing director of sales for its North American healthcare business unit says ongoing merger and acquisitions in health care creates lots of questions on how to best integrate data. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 13, 2018 Category: Pharmaceuticals Authors: Tracey Drury Source Type: news

RxSafe Provides Answers in Wake of Amazon/PillPack
Amazon rocked the pharmacy world in a big way, with the announcement of its estimated $1 billion acquisition of PillPack. How does the Amazon/PillPack deal impact independent community pharmacies?(PRWeb July 13, 2018)Read the full story at https://www.prweb.com/releases/2018/07/prweb15625740.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 13, 2018 Category: Pharmaceuticals Source Type: news

Join the Conversation: Medtech M & amp;A Trends
video-1531312898.mp4 MD+DI News Editor Amanda Pedersen talks about recent M&A trends in medtech and the attributes that make companies stand out as potential acquisition targets. Here is a link to our recently-published list of the 25 Most Attractive Medtech Companies on the M&A Radar, which is mentioned in the video above.   (Source: MDDI)
Source: MDDI - July 12, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Ellis Medicine decides no merger or affiliations
Ellis Medicine, the Albany region's third-largest hospital system, will remain independent after the board decided against affiliating or merging with other health care organizations. The Schenectady hospital system, which has 438 beds and more than 3,500 employees, announced Thursday that it will retain local control after the Ellis board spent two years reviewing proposals from inside and outside the region. "There is an element of pride in what we are doing," said CEO Paul Milton. At a time… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 12, 2018 Category: Pharmaceuticals Authors: Robin K. Cooper Source Type: news

Mediware adds new office with East Coast acquisition
Lenexa-based Mediware Information Systems continues its acquisition streak with a Massachusetts-based company. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 12, 2018 Category: American Health Authors: Elise Reuter Source Type: news

Synteract expands East Coast presence with acquisition
A West Coast contract research organization with an office in Morrisville is expanding its East Coast presence with the acquisition of a New Jersey firm. Synteract, headquartered in the San Diego area, has purchased Cu-Tech, bulking up the California company's services in the dermatology arena. Terms of the deal were not disclosed. “This gives us a nice expansion in a geographic region where it’s clearly very advantageous to have a presence,” says Synteract Chief Commercial Officer Jack Shannon. “Synteract… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 12, 2018 Category: American Health Authors: Jennifer Henderson Source Type: news

Stryker ortho group prez Floyd to retire, Scannell to take prez, COO role
Stryker (NYSE:SYK) said earlier this week that its orthopedics group prez David Floyd will retire, effective at the end of next June, and that it has appointed Timothy Scannell as its new prez and COO, effective August 1. Floyd has been with Stryker since 2012, and will stay on as group prez and advisor to the CEO through to his retirement date, the Kalamazoo, Mich.-based company said. Scannelle joined Stryker in 1990 serving in leadership roles in sales and marketing, and has risen through the company to the role of group president, most recently for the company’s medsurg & neurotechnology divisions. &ldquo...
Source: Mass Device - July 12, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News personnel-moves Stryker Source Type: news

A time to celebrate
This year, our union celebrates an important milestone: our 25th anniversary. Formed by the merger of three great unions – NALGO, NUPE and COHSE – we were told that our efforts were doomed to failure. We were told that UNISON would not work. In the years since, UNISON’s downfall has been predicted on countless occasions by opponents who constantly underestimated our union and our members. Of course, we all know how wrong the doom-mongers were. As the people who heal us, educate us, keep us safe and ensure that we receive care, support and vital services every single day, UNISON people are special people, ...
Source: UNISON meat hygiene - July 12, 2018 Category: Food Science Authors: Dave Prentis Tags: Article Magazine Source Type: news

Asahi Intecc to buy RetroVascular for $26m
Asahi Intecc said early this month that its board of directors agreed to acquire RetroVascular in a deal worth approximately $25.9 million. Menlo Park, Calif.-based RetroVascular is developing cardiological tools for percutaneous transluminal coronary angioplasty procedures, specifically to treat chronic total occlusions. Asahi said that it has maintained a collaborative relationship with RetroVascular to develop the PTCA treatment, which incorporates the use of plasma energy technology with the intention of improving PTCA treatment results. Asahi Intecc said it will look for ways to incorporate the plasma energy technolog...
Source: Mass Device - July 12, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Mergers & Acquisitions Asahi Intecc Source Type: news

FDA approves next-gen MitraClip from Abbott
Abbott (NYSE:ABT) won FDA approval for the third generation of its MitraClip transcatheter heart valve repair device, the company said today. Acquired in the $410 million acquisition of Evalve back in 2009, MitraClip won its first FDA nod in 2013. Abbott said today that the latest iteration won CE Mark approval in the European Union earlier this year. The new version upgrades MitraClip’s steering, navigation and positioning capabilities and a second clip size with expanded reach, the Chicago-area healthcare giant said. “Abbott engineers designed these enhancements based on feedback from doctors to improve ...
Source: Mass Device - July 12, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Cardiac Implants Food & Drug Administration (FDA) Regulatory/Compliance Abbott Source Type: news